Bisphosphonates and oesophageal cancer risk: where are we now?

Bisphosphonates and oesophageal cancer risk: where are we now?

Opis bibliograficzny
Główni autorzy:	Rozenberg, S, Dutton, S
Format:	Journal article
Język:	English
Wydane:	2011

Podobne zapisy

Where are we now and where are we headed?
od: Ewan A. Langan
Wydane: (2023-06-01)

Inflammatory breast cancer: Where are we now?
od: Filipović Slađana
Wydane: (2003-01-01)

Onchodermatitis: Where Are We Now?
od: Michele E. Murdoch
Wydane: (2018-09-01)

Facing the Wildfire Spread Risk Challenge: Where Are We Now and Where Are We Going?
od: Jingjing Sun, i wsp.
Wydane: (2023-06-01)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
od: Michał P. Wasilewicz, i wsp.
Wydane: (2023-04-01)

Risk-reducing surgery for breast and ovarian cancer risks - where are we now?
od: Hallowell N, i wsp.
Wydane: (2012-04-01)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
od: Gordon A. McLorie
Wydane: (2008-01-01)

CAR-T cell therapy: Where are we now, and where are we heading?
od: Jia-Yi Wang, i wsp.
Wydane: (2023-10-01)

Targeting therapy in pemphigus: Where are we now and where are we going?
od: Kailibinuer Abulikemu, i wsp.
Wydane: (2023-06-01)

Myocardial T1 mapping: where are we now and where are we going?
od: Abdel-Gadir A, i wsp.
Wydane: (2014-11-01)

On Taxation of the Digital Economy. Where Are We Now and Where Are We Going?
od: Alin IRIMIA, i wsp.
Wydane: (2021-11-01)

Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going
od: Carlotta Mazzitelli, i wsp.
Wydane: (2023-03-01)

Skeletal muscle and childhood cancer: Where are we now and where we go from here
od: Chelsea G. Goodenough, i wsp.
Wydane: (2021-06-01)

Microbiota and Obesity: Where Are We Now?
od: Andrea Ballini, i wsp.
Wydane: (2020-11-01)

Cannabinoids in Periodontology: Where Are We Now?
od: Yésica Carmona Rendón, i wsp.
Wydane: (2023-11-01)

Crop Improvement: Where Are We Now?
od: Pierre Sourdille, i wsp.
Wydane: (2022-09-01)

Epilepsy and psychosis– where are we now?
od: I. Pereira, i wsp.
Wydane: (2021-04-01)

Genetics of migraine: where are we now?
od: Lou Grangeon, i wsp.
Wydane: (2023-02-01)

Osteochondral techniques: where are we now?
od: Giovanna Medina, i wsp.
Wydane: (2023-03-01)

Editorial: This Is Where We Dance Now
od: Harmony Bench, i wsp.
Wydane: (2021-07-01)

Tuberculosis elimination: where are we now?
od: Alberto Matteelli, i wsp.
Wydane: (2018-06-01)

Depression research: where are we now?
od: Lee Saebom, i wsp.
Wydane: (2010-03-01)

Intracranial Atherosclerosis: Where Are We Now?
od: Jong S. Kim
Wydane: (2017-09-01)

Where we live now [kasetvideo]
Wydane: (1979)

Security training: where are we now?
od: Koenraad Van Brabant
Wydane: (1999-04-01)

Immune checkpoint inhibitors in the treatment of oesophageal squamous cell carcinoma: where are we and where are we going?
od: Ning Chen, i wsp.
Wydane: (2023-08-01)

Where we have been, where we are now, and where we might be heading : Where next for the coaching relationship?
od: Alanna O'Broin
Wydane: (2016-12-01)

Polygenic risk scores for complex diseases: where are we now?
od: Loh, Marie, i wsp.
Wydane: (2023)

Polygenic risk scores for complex diseases: where are we now?
od: Marie Loh, i wsp.
Wydane: (2023-01-01)

Adjuvant treatment for high risk melanoma. Where are we now?
od: Anand Sharma, i wsp.
Wydane: (2011-12-01)

Adjuvant treatment for high risk melanoma. Where are we now?
od: Anand Sharma, i wsp.
Wydane: (2011-12-01)

Editorial: Where Are We Now and Where Do We Go From Here
od: Gabriele Manganaro
Wydane: (2022-01-01)

Yellow fever control in Cameroon: Where are we now and where are we going?
od: Mimbouga Julienne, i wsp.
Wydane: (2008-02-01)

Reflection for the undergraduate on writing in the portfolio: where are we now and where are we going?
od: MOHAMED H AHMED
Wydane: (2018-07-01)

Pharmacological Therapy for COVID-19: Where Are We Now and Where Are We Going?
od: Baha Eldin Hassan Juma, i wsp.
Wydane: (2020-04-01)

Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go?
od: Gianluca Screm, i wsp.
Wydane: (2024-04-01)

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
od: Omarini C, i wsp.
Wydane: (2018-01-01)

Advances in digital CBT: where are we now, and where next?
od: Thew, G, i wsp.
Wydane: (2022)

Entomology in South Africa: Where do we come from, where are we now and where are we going?
od: Jan H. Giliomee
Wydane: (2013-01-01)

CAR-T Cell Therapy in Ovarian Cancer: Where Are We Now?
od: Clare Cutri-French, i wsp.
Wydane: (2024-04-01)